Trial

Common acne medication can slow progress of relapsing-remitting MS, trial shows
www.news-medical.net

A Canadian clinical trial led by researchers at the University of Calgary’s Hotchkiss Brain Institute, at the Cumming School of Medicine, shows that minocycline, a common acne medication, can slow the progress of relapsing-remitting multiple sclerosis (MS) in people who have recently experienced their first symptoms.

6
Like
Save
Drinking beetroot juice reduces high blood pressure, trial shows
www.medicalnewstoday.com

The first figure is the reduction in systolic pressure (when the heart is pushing) and the second figure is reduction in diastolic pressure (when the heart is relaxing). For many patients, the 8/4 mmHg reduction brought their blood pressure back into …

13
Like
Save
Clinical Trial Of Auxilium's Xiaflex Shows It To Be Effective In Smoothing …
www.doctortipster.com

Almost everyone is aware what cellulite is, where once smooth skin was, now are ripples. It happens to both men and women as they put on weight and age. Because it's thought to be unsightly, many researchers have been searching for ways to reduce and …

9
Like
Save
Peanut butter killed his mom; Now son watches company brass stand trial
kfor.com

Shirley Mae Almer contracted a urinary tract infection around Thanksgiving 2008 and checked into the Good Samaritan, a short-term care facility in Brainerd, Minnesota. Her daughter Ginger Lorentz came to visit Almer and made her toast slathered with …

12
Like
Save
Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints
www.reuters.com

The injectable drug, alirocumab, is from a new class of medicines called PCSK9 inhibitors, which are also being developed by Amgen Inc and Pfizer Inc. If approved, they could lower "bad" LDL cholesterol in a new way and reap multibillion-dollar sales.

13
Like
Save
Halozyme cellulite drug gets positive trial results
www.utsandiego.com

Halozyme Therapeutics's cellulite drug, HTI-501 improved cellulite appearance in a Phase 1/2 trial, the San Diego biotech said Tuesday. The trial met the main goal of improving cellulite appearance in the treated areas of skin, as judged by doctors 28 …

11
Like
Save
Amgen cholesterol drug meets goal of 3rd late stage trial
www.reuters.com

(Reuters) – A cholesterol fighter developed by Amgen Inc from a highly promising new class of medicines significantly lowered levels of "bad" LDL cholesterol in a late stage trial in patients unable to tolerate statin drugs, the company said on Thursday.

14
Like
Save
Early Promise in Drug Trial for Fighting Cholesterol
www.nytimes.com

A new type of lipid-lowering drug being developed by Sanofi and Regeneron Pharmaceuticals cut cholesterol levels by about half in its first late-stage clinical trial, the companies will announce on Wednesday.

9
Like
Save
UPDATE 1-Regeneron, Sanofi drug slashes cholesterol in late-stage trial
www.reuters.com

Oct 16 (Reuters) – A new type of cholesterol drug being developed by Regeneron Pharmaceuticals Inc and Sanofi SA, when used by itself, cut levels of "bad" LDL cholesterol almost in half in the first of a dozen late-stage trials of the injectable medicine.

6
Like
Save